BOSTON—Paul Szafir, a leading architect in the cGMP design field, joins the Boston studio of Perkins&Will as associate director of process architecture and cGMP design. Szafir’s arrival ushers in a period of exciting, continued growth of cGMP services within the firm’s Science and Technology practice. With over fifteen years of experience spanning architecture and engineering, Szafir specializes in biopharmaceutical cGMP facility design for clinical research and commercial manufacturing. He has helped deliver projects both locally and nationally for notable pharmaceutical companies including Biogen, CRISPR Therapeutics, Pfizer, and ThermoFisher.
“cGMP facilities lie at the intersection of novel science, innovative design, and complex engineering,” states Dr. Jim Levin, the director of process architecture and cGMP design in Perkins&Will’s Boston studio. ”With Paul on the team, I am excited to leverage our shared expertise to deliver efficient and high-quality facilities that produce life-saving therapies.”
A Powerful Partnership
Szafir joins Levin in co-leading the cGMP practice, strengthening the firm’s capabilities to deliver holistic planning and design services. Together, Levin and Szafir will blend their specialized expertise to solve complex problems and realize high project aspirations. As a Board-certified veterinarian, former Senior VP of a pharmaceutical company, and a veteran lab manager, Levin brings a uniquely user-centric perspective to designing clean room and manufacturing spaces. Working most recently within an engineering-focused firm, Szafir’s expertise in capacity, compliance, and regulatory requirements will elevate the delivery of technically focused solutions.
